Navigation Links
Zymes LLC's Omega-3 Enhanced Water OmegaChill to be Distributed at NFL Alumni Super Bowl XLIV Weekend Events on February 5-7th, 2010
Date:2/3/2010

HASBROUCK HEIGHTS, N.J., Feb. 3 /PRNewswire/ -- Zymes LLC is pleased to announce that OmegaChill, the world's first Omega-3 enhanced water, will be sampled at the NFL Alumni's Super Bowl XLIV Weekend events on February 5-7th, 2010, in Miami, Florida.  This presence of OmegaChill at Super Bowl XLIV Weekend events along with the NFL Alumni's interest in products promoting long term heart and mind health will serve as keynotes to Zymes LLC's launch of OmegaChill into the South Florida retail marketplace.

"We are extremely excited to have OmegaChill highlighted during the festivities surrounding Super Bowl XLIV," said Mr. Vincent Morano, President and CEO of Zymes LLC.  "More importantly our product has gained consumer attraction by the growing recognition of Omega-3s (EPA/DHA) beneficial impact on heart and mind health.  We are enthused by the strong interest expressed in OmegaChill by the South Florida retail marketplace."

In the spring of 2009, Zymes LLC, announced the successful bottling and launch of the world's first Omega-3 enhanced water, OmegaChill (http://www.omegachill.com).  This innovative enhanced water uses Zymes' patented PTS technology to solubilize and stabilize fish-derived Omega-3s.  The resulting beverage delivers 50mg of EPA/DHA and has long-term shelf-stability at room temperature.  The beverage also contains Vitamins C, E, B3, B5, B6, B12, and a natural sweetener, Stevia with zero calories per bottle.  The beverage is currently available in two flavors, Clearberry and Lemon-lime (lemon-lime contains electrolytes).  While Zymes LLC is seeking additional distribution partners for its OmegaChill enhanced waters, the PTS technology is available for licensing for other food and beverage categories.

About Zymes LLC:

Zymes LLC is a bioscience company based in Hasbrouck Heights, NJ that provides innovative solutions to its partners and consumers through proprietary science and technology, enabling new products to enhance the well-being of people.  For more information please visit www.zymes.com or www.omegachill.com.

SOURCE Zymes LLC

RELATED LINKS
http://www.zymes.com
http://www.omegachill.com

'/>"/>

SOURCE Zymes LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. MGH researchers describe new way to identify, evolve novel enzymes
3. Unlocking the function of enzymes
4. Iowa State researcher studies how enzymes break down cellulose
5. Epigenetic research uncovers new targets for modification enzymes
6. Biochemists manipulate fruit flavor enzymes
7. Newly found enzymes may play early role in cancer
8. New drug agent knocks out multiple enzymes in cancer pathway
9. New book, Untangling the Double Helix, explores enzymes responsible for maintaining genome integrity
10. Powe Award supports research on how enzymes enable the pathogenicity of 2 human disease organisms
11. Developing enzymes to clean up pollution by explosives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... 7, 2016 Regen BioPharma Inc. (OTCQB: ... of Molecular Sciences a team of scientists in ... have demonstrated that expression of NR2F6 in patients with early ... NR2F6 in patient,s cervical cancer tissue as well as in ... "This is an interesting study and the first that I ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... website, http://www.autoreactors.com and online shopping cart. The new website has been ... functionality. These essential digital components allow customers to access detailed product information, read ...
(Date:12/6/2016)... , Dec. 6, 2016 The American Botanical ... adoption of arnica ( Arnica montana ) through ... ABC,s HerbMedPro database, a comprehensive, interactive ... and clinical research data on the uses and ... Naturopathica, a wellness company with healing ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Osteoarthritis Research Society International ... Administration (FDA) to consider OA as a serious disease. As an organization of ... population of OA patients, many of whom may experience progressive disability and decreased ...
Breaking Biology Technology: